AB

Amerisourcebergen CorpNYSE ABC Stock Report

Last reporting period 30 Jun, 2023

Updated —

Last price

Market cap $B

36.15

Large

Exchange

XNYS - New York Stock Exchange, Inc

ABC Stock Analysis

AB

Uncovered

Amerisourcebergen Corp is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

45/100

Low score

Market cap $B

36.15

Dividend yield

Shares outstanding

202.26 B

AmerisourceBergen Corp. engages in the provision of pharmaceutical products and business solutions that improve access to care. The company is headquartered in Conshohocken, Pennsylvania and currently employs 39,000 full-time employees. The firm's U.S. Healthcare Solutions segment distributes an offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a wide variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services. This segment consists of Alliance Healthcare, World Courier, Innomar, Profarma, and Profarma Specialty. The firm also focuses on specialty services and a global platform of pharma manufacturer services capabilities.

View Section: Eyestock Rating